- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05883332
A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) Parameters
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The urodynamic study (UDS) procedure will consist of catheter placement and two "runs". Before the start of the procedure, a study staff member will assist the participant with putting on a plastic gas mask. SANO and oxygen will be given through this mask. The dose will be adjusted based on the participant's comfort level but they will not be able to request more gas than allowed. SANO will be administered during catheter placement at the start of the UDS. During the two runs, the participant will either receive SANO (run 1) then oxygen (run 2), or oxygen (run 1) then SANO (run 2).
Before the day of the UDS, participants will be asked questions related to demographics and medical history to determine study eligibility and experience of the treatment. During the UDS, participants will be asked to describe their anxiety and pain levels. Afterwards, they will be asked to complete a 15-20 minute structured interview with a study staff member to learn more about patient experience during UDS.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth Israel Deaconess Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Scheduled for urodynamic study
- Aged 21 to 85 years
- Suitable for inflation of nitrous oxide/oxygen with willingness to undergo two urodynamic study runs during the procedure
- Access to an email and computer
Exclusion Criteria:
- Perioral facial hair impeding good mask seal
- Learning disabilities and/or inability to cognitively complete survey questions
Has any of the following medical conditions:
- Inner ear, bariatric or eye surgery within the last 2 weeks,
- Current emphysematous blebs,
- Severe B-12 deficiency,
- Bleomycin chemotherapy within the past year,
- Heart attack within the past year,
- Stroke within the past year,
- Class III or higher heart failure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SANO (1), Oxygen (2)
All participants will receive self-administered nitrous oxide (SANO) at a range of 25-50% immediately before and during catheter placements. At this time, a participant-preferred level of SANO will be determined. At the start of the first UDS run, SANO will continue at the participant-preferred level that was determined during catheter placement, ensuring that the patient is relaxed but still conversant through the procedure. At the end of the first UDS run, SANO will be turned down to 0%. Participants will then receive 100% oxygen at 10 liters/minute for the duration of their second UDS run. |
Nitrous oxide administered at concentrations of mild sedation (20-50%)
Other Names:
100% oxygen at 10 Liters/minute
|
Experimental: Oxygen (1), SANO (2)
All participants will receive self-administered nitrous oxide (SANO) at a range of 25-50% immediately before and during catheter placements. At this time, a participant-preferred level of SANO will be determined. After catheter placement, SANO will be turned down to 0%. Participants will receive 100% oxygen at 10 liters/minute for the duration of their first UDS run. At the end of the first UDS run, SANO will start at the participant-preferred level that was determined during catheter placement, ensuring that the patient is relaxed but still conversant through the procedure. SANO will be given for the duration of their second UDS run. |
Nitrous oxide administered at concentrations of mild sedation (20-50%)
Other Names:
100% oxygen at 10 Liters/minute
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bladder capacity
Time Frame: Measured at time of max fill during each UDS run
|
Maximum liquid the bladder may hold as measured in milliliters
|
Measured at time of max fill during each UDS run
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intra-Urodynamic Study (UDS) pain
Time Frame: Measured at time of max fill during each UDS run
|
Pain experienced at time of max fill during each UDS run as measured by a Visual Analog Scale for Pain (VAS-P) (range: 0 [no pain] - 10 [worst pain])
|
Measured at time of max fill during each UDS run
|
Intra-Urodynamic Study (UDS) anxiety
Time Frame: Measured at time of max fill during each UDS run
|
Anxiety experienced at time of max fill during each UDS run as measured by a Visual Analog Scale for Anxiety (VAS-A) (range: 0 [no anxiety] - 10 [worst anxiety])
|
Measured at time of max fill during each UDS run
|
Post void residual
Time Frame: Measured at end of void during each UDS run
|
Amount of liquid left in bladder after voiding, as measured in milliliters
|
Measured at end of void during each UDS run
|
Max flow rate
Time Frame: Measured during the void at the end of each UDS run
|
Maximum rate of void, as measured in milliliters per second
|
Measured during the void at the end of each UDS run
|
Detrusor overactivity
Time Frame: Measured during each UDS run
|
Pressure sensors (which are located on the UDS catheter within the bladder) measure any bladder contractions that should not normally occur while a bladder fills.
Outcome pressures will be measured in centimeters (cm) of water (H2O).
|
Measured during each UDS run
|
Detrusor pressure at maximum flow
Time Frame: Measured during each UDS run
|
Pressure sensors (which are located on the UDS catheter within the bladder) measure the strength of the bladder contraction while the individual is urinating.
Outcome pressures will be measured in centimeters (cm) of water (H2O).
|
Measured during each UDS run
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Heidi Rayala, MD, PhD, Beth Israel Deaconess Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022P-000826
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lower Urinary Tract Symptoms
-
The Royal College of Surgeons of EnglandUniversity College, LondonCompletedUncomplicated Lower Urinary Tract Symptoms
-
National Taiwan University HospitalUnknownDisorder of the Lower Urinary TractTaiwan
-
ProVerum MedicalNot yet recruitingBPH With Symptomatic Lower Urinary Tract Symptoms
-
Baylor Research InstituteForte MedicalCompletedLower Urinary Tract Symptoms | Lower Urinary Tract InfectionUnited States
-
The University of Texas Medical Branch, GalvestonCompletedLower Urinary Tract Symptoms | Lower Gastrointestinal Tract Symptoms
-
Far Eastern Memorial HospitalCompletedPsychiatric Aspects in Women With Lower Urinary Tract SymptomsTaiwan
-
Jagiellonian UniversityPiotr ChlostaCompletedTo Evaluate Lower Urinary Tract Symptoms (LUTS) in PolandPoland
-
Boston Scientific CorporationTerminatedBPH | BPH With Urinary Obstruction | BPH With Urinary Obstruction With Other Lower Urinary Tract SymptomsUnited States, Australia
-
Benaroya Research InstituteVirginia Mason Hospital/Medical CenterUnknownPain | BPH With Urinary Obstruction | BPH With Urinary Obstruction With Other Lower Urinary Tract SymptomsUnited States
-
San Carlo di Nancy HospitalLampugnani Farmaceutici S.p.A. (Nerviano, Milan, Italy)CompletedBPH With Urinary Obstruction With Other Lower Urinary Tract SymptomsItaly
Clinical Trials on Self-Administered Nitrous Oxide
-
Beth Israel Deaconess Medical CenterBrigham and Women's HospitalCompletedPain | Benign Prostatic Hyperplasia | Prostate Cancer | Prostate Adenocarcinoma | Anxiety and Fear | Malignancy | Prostate DiseaseUnited States
-
Beth Israel Deaconess Medical CenterRecruitingProcedural Pain | Pain Catastrophizing | Procedural AnxietyUnited States
-
University of ChicagoNational Institute on Drug Abuse (NIDA)CompletedSubstance-Related Disorders | Opioid-Related DisordersUnited States
-
Baylor UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedMild Cognitive Impairment | Poor Quality SleepUnited States
-
Baylor UniversityUniversity of Michigan; National Center for Complementary and Integrative Health...CompletedBreast Cancer | Hot Flashes | Postmenopausal SymptomsUnited States
-
State University of New York at BuffaloCompleted
-
Ekaterina PogrebtsovaCompletedMental Health Wellness 1
-
Washington University School of MedicineBrain & Behavior Research FoundationCompletedDepressive Disorder, Major | Depressive Disorder, Treatment-ResistantUnited States
-
The University of Tennessee, KnoxvilleBaylor UniversityRecruitingBreast Cancer | Neoplasm Metastasis | Triple Negative Breast Neoplasms | Inflammatory Breast Neoplasms | Inflammatory Breast Cancer Stage IVUnited States
-
Baylor UniversityNational Center for Complementary and Integrative Health (NCCIH)CompletedPoor Quality Sleep | Alzheimer's Disease (Incl Subtypes) | Caregiver StressUnited States